|

Effects of a Telerehabilitation Intervention in the Management of Complications After Breast Cancer Surgery

RECRUITINGN/ASponsored by Fondazione Policlinico Universitario Campus Bio-Medico
Actively Recruiting
PhaseN/A
SponsorFondazione Policlinico Universitario Campus Bio-Medico
Started2023-05-15
Est. completion2026-02
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted

Summary

The most common complaints after breast surgery are postoperative pain reported in up to 68% of patients, musculoskeletal problems in the shoulder and functional limitations in up to 59% of patients after mastectomy and quadrantectomy, reduction in range of motion ( ROM) in 24-53% and strength deficit. The study aims to verify the effectiveness of a telerehabilitation treatment in terms of prevention of possible complications following breast cancer surgery. Primary objective: to examine whether the group of patients undergoing rehabilitation surgery in the immediate post-operative period shows a reduction in the onset of complications compared to the group of patients who followed standard procedures. Secondary objective: to study any preoperative prognostic factors for the onset of complications, to study the effectiveness of the rehabilitation treatment in terms of reduction of painful symptoms, improvement of joint ROM, muscle strength and perceived quality of life.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* diagnosis of breast cancer
* Having undergone quadrantectomy or mastectomy surgery
* Age \> 18 years
* Signature of informed consent

Exclusion Criteria:

* Neurological deficits with sensorimotor impairment of the upper limb
* Cognitive deficits that prevent the completion of questionnaires (MMSE\>24)

Conditions3

Breast CancerBreast NeoplasmsCancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.